By analyzing the two published mRNA expression profiles with chemotherapy treatment in ovarian cancer (GSE 51373, MTAB-7083) obtained from Array Express—functional genomics data (https://www.ebi.ac.uk/arrayexpress/), we found that GLT8D2 mRNA was the most significantly upregulated in chemotherapy resistance and platinum resistance tissues in the both published mRNA expression profiles (Supplementary Fig. 1a, b). Here, GLT8D2 is linked to ovarian carcinoma.